Steven Edward Hall

Steven Edward Hall has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Cerulean Pharma Inc., Forma Therapeutics Holdings, Inc. and Kymera Therapeutics, Inc. In total, 7 filings cover trades dated from 15 April 2014 to 25 August 2020.

Purchases make up the whole of the open-market record (1 purchase, €3.7M). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

Most recently, on 25 November 2020, the filings show a transaction in Forma Therapeutics Holdings, Inc. The last insider purchase was made public on 15 April 2014, 4,591 days ago. Most trades are made public on the day they happen. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.